Compare Definium Therapeutics Inc. Common Shares (DFTX) vs MKS Instruments (MKSI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Definium Therapeutics Inc. Common Shares vs MKS Instruments — how do they compare? Definium Therapeutics Inc. Common Shares trades at $36.88 (market cap $4.59B), while MKS Instruments trades at $265.61 (market cap $17.61B). The key difference: MKS Instruments is far larger — about 3.8× Definium Therapeutics Inc. Common Shares's market cap, and MKS Instruments pays a 0.38% dividend while Definium Therapeutics Inc. Common Shares pays none. Which is the better fit depends on your goals — on Pluang, investors hold Definium Therapeutics Inc. Common Shares for 0 Days and MKS Instruments for 7 Days on average.
| DFTX | MKSI | |
|---|---|---|
Market Cap | $4.59B | $17.61B |
Volume | 2,103,937 | 1,275,355 |
Sector | Health | Technology |
52-Week High | $48.45 | $444.80 |
52-Week Low | $10.68 | $121.26 |
Typical Hold Time | 0 Days | 7 Days |
Enterprise Value | $3.55B | $21.18B |
Dividend Yield | — | 0.38% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Definium Therapeutics Inc. Common Shares
Definium Therapeutics develops investigational treatments for psychiatric and neurological disorders. Formerly MindMed, it focuses on clinical-stage therapies based on novel psychoactive compounds.
Read more on DFTX →About MKS Instruments
MKS develops instruments, systems, and process control solutions for advanced manufacturing. Its technologies serve semiconductor manufacturing, electronics and packaging, photonics, and specialty industrial applications.
Read more on MKSI →
